The structure of Escherichia coli cytosine deaminase.

Cytosine deaminase (CD) catalyzes the deamination of cytosine, producing uracil. This enzyme is present in prokaryotes and fungi (but not multicellular eukaryotes) and is an important member of the pyrimidine salvage pathway in those organisms. The same enzyme also catalyzes the conversion of 5-fluorocytosine to 5-fluorouracil; this activity allows the formation of a cytotoxic chemotherapeutic agent from a non-cytotoxic precursor. The enzyme is of widespread interest both for antimicrobial drug design and for gene therapy applications against tumors. The structure of Escherichia coli CD has been determined in the presence and absence of a bound mechanism-based inhibitor. The enzyme forms an (alphabeta)(8) barrel structure with structural similarity to adenosine deaminase, a relationship that is undetectable at the sequence level, and no similarity to bacterial cytidine deaminase. The enzyme is packed into a hexameric assembly stabilized by a unique domain-swapping interaction between enzyme subunits. The active site is located in the mouth of the enzyme barrel and contains a bound iron ion that coordinates a hydroxyl nucleophile. Substrate binding involves a significant conformational change that sequesters the reaction complex from solvent.

[1]  S. Morris.  The genetic toxicology of 5-fluoropyrimidines and 5-chlorouracil. , 1993, Mutation research.

[2]  W. Hendrickson.  Determination of macromolecular structures from anomalous diffraction of synchrotron radiation. , 1991, Science.

[3]  E. Austin,et al.  A first step in the development of gene therapy for colorectal carcinoma: cloning, sequencing, and expression of Escherichia coli cytosine deaminase. , 1993, Molecular pharmacology.

[4]  M. Uschold,et al.  Methods and applications , 1953 .

[5]  F A Quiocho,et al.  Atomic structure of adenosine deaminase complexed with a transition-state analog: understanding catalysis and immunodeficiency mutations. , 1991, Science.

[6]  T. Sakai,et al.  Antineoplastic effects in rats of 5-fluorocytosine in combination with cytosine deaminase capsules. , 1985, Cancer research.

[7]  S. Doublié.  [29] Preparation of selenomethionyl proteins for phase determination. , 1997, Methods in enzymology.

[8]  R. Wolfenden,et al.  Cytidine deaminase. The 2.3 A crystal structure of an enzyme: transition-state analog complex. , 1994, Journal of molecular biology.

[9]  R. Wolfenden,et al.  Binding of pyrimidin-2-one ribonucleoside by cytidine deaminase as the transition-state analogue 3,4-dihydrouridine and the contribution of the 4-hydroxyl group to its binding affinity. , 1989, Biochemistry.

[10]  G A Petsko,et al.  Crystallographic analysis of the complex between triosephosphate isomerase and 2-phosphoglycolate at 2.5-A resolution: implications for catalysis. , 1990, Biochemistry.

[11]  C Sander,et al.  An evolutionary treasure: unification of a broad set of amidohydrolases related to urease , 1997, Proteins.

[12]  A. Rehemtulla,et al.  Superiority of yeast over bacterial cytosine deaminase for enzyme/prodrug gene therapy in colon cancer xenografts. , 1999, Cancer research.

[13]  Carl Frieden,et al.  Adenosine deaminase converts purine riboside into an analogue of a reactive intermediate: a 13C NMR and kinetic study. , 1987, Biochemistry.

[14]  R. Crystal,et al.  In vivo adenovirus-mediated gene transfer of the Escherichia coli cytosine deaminase gene to human colon carcinoma-derived tumors induces chemosensitivity to 5-fluorocytosine. , 1995, Human gene therapy.

[15]  T. Katsuragi,et al.  Implantable enzyme capsules for cancer chemotherapy from bakers’ yeast cytosine deaminase immobilized on epoxy-acrylic resin and urethane prepolymer , 1987, Applied biochemistry and biotechnology.

[16]  P. Karplus,et al.  The crystal structure of urease from Klebsiella aerogenes. , 1995, Science.

[17]  R. Wolfenden,et al.  The structure of the cytidine deaminase-product complex provides evidence for efficient proton transfer and ground-state destabilization. , 1997, Biochemistry.

[18]  V S Lamzin,et al.  Automated refinement of protein models. , 1993, Acta crystallographica. Section D, Biological crystallography.

[19]  R. Blaese,et al.  Transfer of the bacterial gene for cytosine deaminase to mammalian cells confers lethal sensitivity to 5-fluorocytosine: a negative selection system. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[20]  J. Thornton,et al.  PROCHECK: a program to check the stereochemical quality of protein structures , 1993 .

[21]  D E McRee,et al.  XtalView/Xfit--A versatile program for manipulating atomic coordinates and electron density. , 1999, Journal of structural biology.

[22]  Axel T. Brunger,et al.  Assessment of Phase Accuracy by Cross Validation: the Free R Value. Methods and Applications , 1993 .

[23]  D. J. Porter.  Escherichia coli cytosine deaminase: the kinetics and thermodynamics for binding of cytosine to the apoenzyme and the Zn(2+) holoenzyme are similar. , 2000, Biochimica et biophysica acta.

[24]  R. Wolfenden,et al.  Enzyme-substrate complexes of adenosine and cytidine deaminases: absence of accumulation of water adducts. , 1996, Biochemistry.

[25]  F A Quiocho,et al.  A pre-transition-state mimic of an enzyme: X-ray structure of adenosine deaminase with bound 1-deazaadenosine and zinc-activated water. , 1993, Biochemistry.

[26]  D. J. Porter,et al.  Cytosine deaminase. The roles of divalent metal ions in catalysis. , 1993, The Journal of biological chemistry.

[27]  R. Wolfenden,et al.  Transition-state stabilization by adenosine deaminase: 1,6-addition of water to purine ribonucleoside, the enzyme's affinity for 6-hydroxy-1,6-dihydropurine ribonucleoside, and the effective concentration of substrate water at the active site. , 1989, Biochemistry.

[28]  E A Merritt,et al.  Raster3D: photorealistic molecular graphics. , 1997, Methods in enzymology.

[29]  P. Linsley,et al.  Cloning, overexpression, and purification of cytosine deaminase from Saccharomyces cerevisiae. , 1998, Protein expression and purification.

[30]  C. Richards,et al.  In vivo antitumor activity of 5-fluorocytosine on human colorectal carcinoma cells genetically modified to express cytosine deaminase. , 1993, Cancer research.

[31]  C. Sander,et al.  Protein structure comparison by alignment of distance matrices. , 1993, Journal of molecular biology.

[32]  G. Dachs,et al.  Gene directed enzyme/prodrug therapy of cancer: Historical appraisal and future prospectives , 2001, Journal of cellular physiology.

[33]  Z. Otwinowski,et al.  [20] Processing of X-ray diffraction data collected in oscillation mode. , 1997, Methods in enzymology.

[34]  V S Lamzin,et al.  Automated refinement for protein crystallography. , 1997, Methods in enzymology.

[35]  T. Katsuragi,et al.  Cytosine Deaminase from Escherichia coli-Production, Purification, and Some Characteristics , 1986 .

[36]  F A Quiocho,et al.  Complexes of adenosine deaminase with two potent inhibitors: X-ray structures in four independent molecules at pH of maximum activity. , 1998, Biochemistry.

[37]  R J Read,et al.  Crystallography & NMR system: A new software suite for macromolecular structure determination. , 1998, Acta crystallographica. Section D, Biological crystallography.

[38]  K. Wilson,et al.  A new proposal for urease mechanism based on the crystal structures of the native and inhibited enzyme from Bacillus pasteurii: why urea hydrolysis costs two nickels. , 1999, Structure.

[39]  B. Stoddard,et al.  Crystallization and preliminary X-ray analysis of bacterial cytosine deaminase. , 2001, Acta crystallographica. Section D, Biological crystallography.